← Browse by Condition
Medical Condition

second line therapy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07320586 Phase 2
Recruiting

Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Enrollment
40 pts
Location
China
Sponsor
Shandong Tumor Hospital
View Trial →